1998
DOI: 10.1159/000029817
|View full text |Cite
|
Sign up to set email alerts
|

Bioequivalence of Topical Dermatological Dosage Forms – Methods of Evaluation of Bioequivalence

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
72
0
2

Year Published

2004
2004
2015
2015

Publication Types

Select...
8
1

Relationship

3
6

Authors

Journals

citations
Cited by 72 publications
(74 citation statements)
references
References 0 publications
0
72
0
2
Order By: Relevance
“…These parameters and the drug penetration profiles provide information with which to assess bioavailability and demonstrate bioequivalence between different formulations. It has been suggested that since the stratum corneum, SC, is the principal barrier to drug absorption, that kinetic data of drug passage through this layer can be related to bioavailability in the target tissue [1][2][3].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…These parameters and the drug penetration profiles provide information with which to assess bioavailability and demonstrate bioequivalence between different formulations. It has been suggested that since the stratum corneum, SC, is the principal barrier to drug absorption, that kinetic data of drug passage through this layer can be related to bioavailability in the target tissue [1][2][3].…”
Section: Introductionmentioning
confidence: 99%
“…The tape stripping technique has attracted considerable interest from regulatory bodies, such as the US Food and Drug Administration, as a means to determine dermato-pharmacokinetic parameters, and ultimately test bioequivalence between formulations [2,3]. Tape stripping involves the sequential removal of layers of the stratum corneum using adhesive tapes.…”
Section: Introductionmentioning
confidence: 99%
“…The tape-stripping procedure (see the previous section) was performed by exerting the pressure just with the forefinger. To increase reproducibility, the procedure was carried out by the same person according to the AAPS/FDA Workshop report (29) and the Guidance for Industry (30).…”
Section: In-vivo Experimentsmentioning
confidence: 99%
“…The implantation procedure involves initial insertion of cannnulae into the skin and subsequent threading of the DMD membranes through the cannulae within the volar aspect of the forearm of human volunteers is illustrated in Figure 9 (Tettey-Amlalo, 2009). Once the microdialysis membranes have been inserted through the cannulae and placed under the skin, the probes are connected to a microdialysis pump (Figure 10) DMD has been considered as a promising technique for the assessment of bioavailability and bioequivalence of topical formulations and has attracted a great deal of interest among research scientists, dermatologists, and the pharmaceutical industry (Groth, 1996;Shah et al, 1998a;Shah et al, 1998b;Benfeldt et al, 2007). The technique is minimally invasive and capable of producing concentration-time profiles sampled directly in the dermis, the target tissue, and is therefore suited to study the local and/or regional delivery of drugs following topical administration.…”
Section: Dermal Microdialysismentioning
confidence: 99%